NITESH PRIYADARSHI

Dr. NITESH PRIYADARSHI

National Agri-Food Biotechnology Institute, Mohali, India
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VSVijaya Bharathi Srinivasan
Vijaya Bharathi Srinivasan
BSBharat Bhushan Singh
Bharat Bhushan Singh
NPNITESH PRIYADARSHI
NITESH PRIYADARSHI
NCNeeraj Kumar Chauhan
Neeraj Kumar Chauhan
GRGovindan Rajamohan
Govindan Rajamohan
Multidrug resistant Klebsiella pneumoniae have caused major therapeutic problems worldwide due to the emergence of the extended-spectrum β-lactamase producing strains. Although there are >10 major facilitator super family (MFS) efflux pumps annotated in the genome sequence of the K. pneumoniae bacillus, apparently less is known about their physiological relevance. Insertional inactivation of kpnGH resulting in increased susceptibility to antibiotics such as azithromycin, ceftazidime, ciprofloxacin, ertapenem, erythromycin, gentamicin, imipenem, ticarcillin, norfloxacin, polymyxin-B, piperacillin, spectinomycin, tobramycin and streptomycin, including dyes and detergents such as ethidium bromide, acriflavine, deoxycholate, sodium dodecyl sulphate, and disinfectants benzalkonium chloride, chlorhexidine and triclosan signifies the wide substrate specificity of the transporter in K. pneumoniae. Growth inactivation and direct fluorimetric efflux assays provide evidence that kpnGH mediates antimicrobial resistance by active extrusion in K. pneumoniae. The kpnGH isogenic mutant displayed decreased tolerance to cell envelope stressors emphasizing its added role in K. pneumoniae physiology. The MFS efflux pump KpnGH involves in crucial physiological functions besides being an intrinsic resistance determinant in K. pneumoniae.

1 June 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
AKAnupamjeet Kaur
Anupamjeet Kaur
SMSukhmani Mann
Sukhmani Mann
AKAmandeep Kaur
Amandeep Kaur
NPNITESH PRIYADARSHI
NITESH PRIYADARSHI
BGBhupesh Goyal
Bhupesh Goyal
DGDeepti Goyal
Deepti Goyal

18 October 2022
Verified
Book Chapter
Closed access
PDF file
RDRahul Dilawari
Rahul Dilawari
NKNavneet Kaur
Navneet Kaur
NPNITESH PRIYADARSHI
NITESH PRIYADARSHI
IPIsh Prakash
Ish Prakash
APAnupam Patra
Anupam Patra
MIMd Aminul Islam
Md Aminul Islam

18 December 2020 in Frontiers in Nanotechnology
Verified
Journal Article
Open access
PDF file
Ritika GuptaRitika Gupta
Ritika Gupta
PSPoonam Sagar
Poonam Sagar
NPNITESH PRIYADARSHI
NITESH PRIYADARSHI
SKSunaina Kaul
Sunaina Kaul
RSRajat Sandhir
Rajat Sandhir
NSNitin Kumar Singhal
Nitin Kumar Singhal
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic has been validated as an extreme clinical calamity and has affected several socio-economic activities globally. Proven transmission of this virus occurs through airborne droplets from an infected person. The recent upsurge in the number of infected individuals has already exceeded the number of intensive care beds available to patients. These extraordinary circumstances have elicited the need for the development of diagnostic tools for the detection of the virus and, hence, prevent the spread of the disease. Early diagnosis and effective immediate treatment can reduce and prevent an increase in the number of cases. Conventional methods of detection such as quantitative real-time polymerase chain reaction and chest computed tomography scans have been used extensively for diagnostic purposes. However, these present several challenges, including prolonged assay requirements, labor-intensive testing, low sensitivity, and unavailability of these resources in remote locations. Such challenges urgently require fast, sensitive, and accurate diagnostic techniques for the timely detection and treatment of coronavirus disease 2019 (COVID-19) infections. Point-of-care biosensors that include paper- and chip-based diagnostic systems are rapid, cost-effective, and user friendly. In this article nanotechnology-based potential biosensors for SARS-CoV-2 diagnosis are discussed with particular emphasis on a lateral flow assay, a surface-enhanced Raman scattering-based biosensor, a localized surface plasmon resonance-based biosensor, Förster resonance energy transfer, an electrochemical biosensor, and artificial intelligence-based biosensors. Several biomolecules, such as nucleic acids, antibodies/enzymes, or aptamers, can serve as potential detection molecules on an appropriate platform, such as graphene oxide, nanoparticles, or quantum dots. An effective biosensor can be developed by using appropriate combinations of nanomaterials and technologies.

1 June 2019 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
SKShimayali Kaushal
Shimayali Kaushal
NPNITESH PRIYADARSHI
NITESH PRIYADARSHI
APAnil Kumar Pinnaka
Anil Kumar Pinnaka
SSSanjeev Soni
Sanjeev Soni
ADAkash Deep
Akash Deep
NSNitin Kumar Singhal
Nitin Kumar Singhal

13 September 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SKSunaina Kaul
Sunaina Kaul
PSPoonam Sagar
Poonam Sagar
Ritika GuptaRitika Gupta
Ritika Gupta
PGPriyanka Garg
Priyanka Garg
NPNITESH PRIYADARSHI
NITESH PRIYADARSHI
NSNitin Kumar Singhal
Nitin Kumar Singhal